About Us

Growing in the USA. The Company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities.

Play Video


Business Model

Significant Developments

Our Timeline

July 2018
December 2018
April 2019
Jun 2019
Jun 2020

Completion of $4.5 million financing

Enter into an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand (outside of Washington State)
Completion of $10,830,000 debenture financing
Investment completed in Applied Cannabis Sciences Partnership. Filed three applications in New Jersey
Agreement to invest up to $1 million in Immunoflex biotech venture


Our Team

Karl Kottmeier

President and CEO

Sheldon Aberman

Chief Cannabis Officer and Director

Doug Ford

Chief Financial Officer

Kirk Gamley


Scroll to Top